| Q55499204 | Association Between Gestational Hypertension and Risk of Cardiovascular Disease Among 617 589 Norwegian Women. |
| Q46306526 | Blood laboratory testing for early prediction of preeclampsia: chasing the finish line or at the starting blocks? |
| Q112285355 | Changes in Serum Cytokines Throughout Pregnancy in Women With Polycystic Ovary Syndrome |
| Q33596750 | Comparison of risk factors and outcomes of gestational hypertension and pre-eclampsia |
| Q112288199 | Cytokine Patterns in Maternal Serum From First Trimester to Term and Beyond |
| Q58127450 | Hypertensive Disorders of Pregnancy and Future Maternal Cardiovascular Risk |
| Q39158013 | Interleukin-1 Receptor Antagonist Polymorphism and Birth Timing: Pathway Analysis Among African American Women. |
| Q37694496 | Lower Serum Vitamin D Metabolite Levels in Relation to Circulating Cytokines/Chemokines and Metabolic Hormones in Pregnant Women with Hypertensive Disorders |
| Q91607245 | Pregnancy-associated cardiac dysfunction and the regulatory role of microRNAs |
| Q53693460 | Serum Levels of Interleukin-13 Increase in Subjects with Insulin Resistance but Do Not Correlate with Markers of Low-Grade Systemic Inflammation. |
| Q92892860 | Serum cytokine patterns in first half of pregnancy |
| Q52715243 | The Role of Interleukin-10 in the Pathophysiology of Preeclampsia. |
| Q92584088 | lncRNA FOXD2-AS1 affects trophoblast cell proliferation, invasion and migration through targeting miRNA |